A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).
Trial details
- Registry ID
- NCT05608681
- Phase
- Phase 1, Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Trial to Evaluate EP-104GI in Adults With Eosinophilic Esophagitis (EoE).NCT05608681 | EPRX | Phase 1, Phase 2 | Recruiting | 2026-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |